CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data

Abstract Breast cancer patients with residual disease after neoadjuvant chemotherapy and surgery may benefit from additional anti-cancer therapies. Capecitabine, an oral antimetabolite and prodrug of 5-Flurouracil, has been approved for treating metastatic breast cancer. One randomized clinical tria...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jo Anne Zujewski, Lawrence Rubinstein
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/e9264fc7d1f847c1825dcf1a2d935aed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares